-
My Account
In App
My Account
| Particulars | This Scheme | Category |
|---|---|---|
| No. of Stocks | 20 | 77.02 |
| Top 5 Stock Weight | 52.04% | 36.98% |
| Top 10 Stock Weight | 77.3% | 54.12% |
| Top 3 Sector Weight | 99.97% | 34.2% |
| Particulars | This Scheme | Category |
|---|---|---|
| Average mcap (Cr) | 34707.26 | 112270.48 |
| Holdings in large cap stocks | 43.53% | 50.55% |
| Holdings in mid cap stocks | 25.32% | 15.75% |
| Holdings in small cap stocks | 0% | 8.59% |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 20.1 | 18.14% | 0.00% | 22.25% (Oct 2024) | 17.77% (Sep 2025) | 11.86 k | 5.00 |
| # Divis Laboratories Ltd. | Pharmaceuticals | 9.6 | 8.71% | 0.00% | 9.11% (May 2025) | 7.65% (Sep 2025) | 1.43 k | 0.00 |
| # Max Healthcare Institute Ltd. | Hospital | 9.6 | 8.69% | 0.00% | 9.81% (Jun 2025) | 8.28% (Nov 2024) | 8.36 k | 3.00 |
| # Cipla Ltd. | Pharmaceuticals | 9.5 | 8.60% | 0.00% | 9.79% (Feb 2025) | 8.77% (Jun 2025) | 6.33 k | 2.00 |
| # Apollo Hospitals Enterprises Ltd. | Hospital | 8.7 | 7.90% | 0.00% | 8.03% (Aug 2025) | 7.37% (Mar 2025) | 1.14 k | 1.00 |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 8.2 | 7.43% | 0.00% | 9.1% (Dec 2024) | 7.7% (Mar 2025) | 6.85 k | 2.00 |
| # Fortis Healthcare Ltd. | Hospital | 6 | 5.43% | 0.00% | 5.34% (Sep 2025) | 0% (Oct 2024) | 5.86 k | 2.00 |
| # Lupin Ltd. | Pharmaceuticals | 5.3 | 4.84% | 0.00% | 6.1% (Dec 2024) | 4.69% (Jul 2025) | 2.72 k | 1.00 |
| # Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 4.2 | 3.79% | 0.00% | 3.98% (Sep 2025) | 3.29% (Oct 2024) | 1.18 k | 1.00 |
| # Laurus Labs Ltd. | Pharmaceuticals | 4.2 | 3.77% | 0.00% | 3.5% (Aug 2025) | 2.15% (Oct 2024) | 4.37 k | 2.00 |
| Stock Invested in |
Sector |
Sector Total |
Value(Mn) |
% of Total Holdings |
1M Change |
1Y Highest Holding |
1Y Lowest Holding |
Quantity |
1M Change in Qty |
M-Cap |
GroupName |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 76.69 | 20.1 | 18.14% | 0.00% | 22.25% (Oct 2024) | 17.77% (Sep 2025) | 11.86 k | 5.00 | Large Cap | 43.53 |
| # Divis Laboratories Ltd. | Pharmaceuticals | 76.69 | 9.6 | 8.71% | 0.00% | 9.11% (May 2025) | 7.65% (Sep 2025) | 1.43 k | 0.00 | Large Cap | 43.53 |
| # Max Healthcare Institute Ltd. | Hospital | 22.02 | 9.6 | 8.69% | 0.00% | 9.81% (Jun 2025) | 8.28% (Nov 2024) | 8.36 k | 3.00 | Other | 31.12 |
| # Cipla Ltd. | Pharmaceuticals | 76.69 | 9.5 | 8.60% | 0.00% | 9.79% (Feb 2025) | 8.77% (Jun 2025) | 6.33 k | 2.00 | Large Cap | 43.53 |
| # Apollo Hospitals Enterprises Ltd. | Hospital | 22.02 | 8.7 | 7.90% | 0.00% | 8.03% (Aug 2025) | 7.37% (Mar 2025) | 1.14 k | 1.00 | Mid Cap | 25.32 |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 76.69 | 8.2 | 7.43% | 0.00% | 9.1% (Dec 2024) | 7.7% (Mar 2025) | 6.85 k | 2.00 | Other | 31.12 |
| # Fortis Healthcare Ltd. | Hospital | 22.02 | 6 | 5.43% | 0.00% | 5.34% (Sep 2025) | 0% (Oct 2024) | 5.86 k | 2.00 | Other | 31.12 |
| # Lupin Ltd. | Pharmaceuticals | 76.69 | 5.3 | 4.84% | 0.00% | 6.1% (Dec 2024) | 4.69% (Jul 2025) | 2.72 k | 1.00 | Large Cap | 43.53 |
| # Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 76.69 | 4.2 | 3.79% | 0.00% | 3.98% (Sep 2025) | 3.29% (Oct 2024) | 1.18 k | 1.00 | Mid Cap | 25.32 |
| # Laurus Labs Ltd. | Pharmaceuticals | 76.69 | 4.2 | 3.77% | 0.00% | 3.5% (Aug 2025) | 2.15% (Oct 2024) | 4.37 k | 2.00 | Other | 31.12 |
| # Aurobindo Pharma Ltd. | Pharmaceuticals | 76.69 | 3.6 | 3.24% | 0.00% | 4.35% (Oct 2024) | 3% (Aug 2025) | 3.15 k | 1.00 | Large Cap | 43.53 |
| # Alkem Laboratories Ltd. | Pharmaceuticals | 76.69 | 3.5 | 3.16% | 0.00% | 3.36% (Oct 2024) | 2.72% (Jul 2025) | 634.00 | 1.00 | Mid Cap | 25.32 |
| # Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 76.69 | 3.2 | 2.90% | 0.00% | 3.23% (Jul 2025) | 2.23% (Apr 2025) | 1.69 k | 0.00 | Mid Cap | 25.32 |
| # Mankind Pharma Ltd. | Pharmaceuticals | 76.69 | 3 | 2.74% | 0.00% | 3.02% (May 2025) | 0% (Oct 2024) | 1.27 k | 0.00 | Other | 31.12 |
| # Zydus Lifesciences Ltd. | Pharmaceuticals | 76.69 | 2.7 | 2.48% | 0.00% | 2.82% (Jan 2025) | 2.38% (Apr 2025) | 2.81 k | 1.00 | Mid Cap | 25.32 |
| # Biocon Ltd. | Pharmaceuticals | 76.69 | 2.5 | 2.28% | 0.00% | 2.36% (Jul 2025) | 1.56% (Apr 2025) | 6.76 k | 3.00 | Mid Cap | 25.32 |
| # Ipca Laboratories Ltd. | Pharmaceuticals | 76.69 | 2 | 1.80% | 0.00% | 2.47% (Dec 2024) | 1.97% (Sep 2025) | 1.56 k | 1.00 | Other | 31.12 |
| # Abbott India Ltd. | Pharmaceuticals | 76.69 | 1.7 | 1.55% | 0.00% | 2.01% (Feb 2025) | 1.59% (Jan 2025) | 59.00 | 0.00 | Mid Cap | 25.32 |
| # Piramal Pharma Ltd. | Pharmaceuticals | 76.69 | 1.4 | 1.26% | 0.00% | 1.25% (Sep 2025) | 0% (Oct 2024) | 6.95 k | 3.00 | Other | 31.12 |
| # Syngene International Ltd. | Healthcare research, analytics & technology | 1.26 | 1.4 | 1.26% | 0.00% | 1.93% (Nov 2024) | 1.24% (Aug 2025) | 2.13 k | 1.00 | Mid Cap | 25.32 |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No new entrants in the portfolio in the last month. | ||||||||
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No complete exits in the portfolio in the last month. | ||||||||
| Stock | Oct 2025 | Sep 2025 | Aug 2025 | Jul 2025 | Jun 2025 | May 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Jan 2025 | Dec 2024 | Nov 2024 | Oct 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 18.14% | 17.77% | 17.95% | 18.49% | 18.70% | 19.63% | 21.20% | 20.63% | 21.76% | 21.90% | 21.87% | 21.89% | 22.25% |
| Cipla Ltd. | 8.60% | 8.94% | 9.34% | 8.79% | 8.77% | 8.95% | 9.36% | 8.95% | 9.79% | 9.46% | 9.03% | 9.60% | 9.50% |
| Max Healthcare Institute Ltd. | 8.69% | 8.76% | 8.96% | 9.31% | 9.81% | 9.08% | 8.76% | 8.99% | 9.18% | 9.16% | 8.99% | 8.28% | 8.42% |
| Divis Laboratories Ltd. | 8.71% | 7.65% | 8.13% | 8.42% | 8.95% | 9.11% | 8.29% | 8.08% | 8.81% | 8.24% | 8.32% | 8.89% | 8.33% |
| Dr. Reddys Laboratories Ltd. | 7.43% | 7.88% | 8.01% | 7.77% | 8.09% | 8.28% | 7.75% | 7.70% | 8.62% | 8.41% | 9.10% | 8.36% | 8.66% |
| Apollo Hospitals Enterprises Ltd. | 7.90% | 7.91% | 8.03% | 7.62% | 7.57% | 7.54% | 7.56% | 7.37% | 7.75% | 8.02% | 7.93% | 7.84% | 7.92% |
| Lupin Ltd. | 4.84% | 4.89% | 4.78% | 4.69% | 4.85% | 5.13% | 5.43% | 5.40% | 5.81% | 5.83% | 6.10% | 5.63% | 5.87% |
| Fortis Healthcare Ltd. | 5.43% | 5.34% | 4.96% | 4.49% | 4.28% | 3.99% | 3.83% | 3.98% | - | - | - | - | - |
| Torrent Pharmaceuticals Ltd. | 3.79% | 3.98% | 3.89% | 3.93% | 3.69% | 3.61% | 3.73% | 3.72% | 3.50% | 3.57% | 3.39% | 3.47% | 3.29% |
| Aurobindo Pharma Ltd. | 3.24% | 3.21% | 3.00% | 3.20% | 3.29% | 3.48% | 3.69% | 3.58% | 3.74% | 3.81% | 4.00% | 4.03% | 4.35% |
| Alkem Laboratories Ltd. | 3.16% | 3.23% | 2.98% | 2.72% | 2.75% | 2.94% | 2.92% | 2.86% | 3.12% | 3.13% | 3.21% | 3.35% | 3.36% |
| Mankind Pharma Ltd. | 2.74% | 2.91% | 2.91% | 2.91% | 2.71% | 3.02% | 2.99% | 2.99% | - | - | - | - | - |
| Laurus Labs Ltd. | 3.77% | 3.46% | 3.50% | 3.44% | 2.94% | 2.59% | 2.54% | 2.65% | 2.62% | 2.67% | 2.54% | 2.54% | 2.15% |
| Glenmark Pharmaceuticals Ltd. | 2.90% | 3.11% | 3.03% | 3.23% | 2.73% | 2.38% | 2.23% | 2.56% | 2.44% | 2.76% | 2.60% | 2.63% | 2.84% |
| Zydus Lifesciences Ltd. | 2.48% | 2.59% | 2.56% | 2.43% | 2.56% | 2.52% | 2.38% | 2.44% | 2.77% | 2.82% | 2.61% | 2.75% | 2.79% |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.04% |
| Net Receivables | Net Receivables | -0.01% |
Your Hard-Earned Money Deserves Safe, Steady Growth 9.80% MUTHOOT MICROFIN LIMITED 2028 ✔️ Coupon: 9.80% ✔️ Rating: CRISIL A+ Positive ✔️ Tenor: 2y 10m (Maturity: 23/Sep/2028) Senior Secured Bond | NBFC Bond | High Return Bond | Listed Muthoot Microfin brings you the perfect blend of security, stability, and steady returns. Invest confidently in a Senior Secured NBFC Bond backed by strong fundamentals and a positive outlook. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJldFlRPT0=/980-muthoot-microfin-limited-2028?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more
Posted by : The Fixed Income
Repost this message
Your Hard-Earned Money Deserves Safe, Steady Growth 9.80% MUTHOOT MICROFIN LIMITED 2028 ✔️ Coupon: 9.80% ✔️ Rating: CRISIL A+ Positive ✔️ Tenor: 2y 10m (Maturity: 23/Sep/2028) Senior Secured Bond | NBFC Bond | High Return Bond | Listed Muthoot Microfin brings you the perfect blend of security, stability, and steady returns. Invest confidently in a Senior Secured NBFC Bond backed by strong fundamentals and a positive outlook. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJldFlRPT0=/980-muthoot-microfin-limited-2028?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
need your suggestion for sbi psu fund direct growth stay or switch View more
Posted by : shravanashok
Dividend last declared by SBI Long Term Equity Fund - regular Plan -IDCW was in the year 2022. Is there any specific reason given by fund managers for non declaration of dividend. Please let me know. View more
Posted by : ravisistla
Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV. View more
Posted by : sunny85deol
